Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Oesophago-gastric Cancer × Oxaliplatin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 398 Stomach Neoplasms 271 Rectal Neoplasms 248 Colonic Neoplasms 181 Pancreatic Neoplasms 155 Neoplasm Metastasis 84 Esophageal Neoplasms 81 Carcinoma, Hepatocellular 54 Adenocarcinoma Of Esophagus 43 Cholangiocarcinoma 40 Neoplasms 39 Biliary Tract Neoplasms 31 Adenocarcinoma 28 Gallbladder Neoplasms 27 Liver Neoplasms 25 Gastrointestinal Neoplasms 25 Esophageal Squamous Cell Carcinoma 21 Bile Duct Neoplasms 17 Carcinoma, Non-Small-Cell Lung 16 Appendiceal Neoplasms 11 Recurrence 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Locally Advanced Rectal Cancer 10 Colorectal Cancer Metastatic 10 Peritoneal Neoplasms 9 Ovarian Neoplasms 8 Carcinoma 7 Breast Neoplasms 7 Digestive System Neoplasms 6 Carcinoma, Renal Cell 6

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡